Biotech ETFs Are Breaking Out on Pfizer’s Array Biopharma Deal
June 17, 2019 at 15:22 PM EDT
Biotech sector exchange traded funds rallied Monday after Pfizer (NYSE: PFE) said it would acquire Array Biopharma Inc. (NasdaqGS: ARRY) in a $10.6 billion deal to bolster its portfolio of cancer fighting drugs in face of rising competition in the generics drug space. Among the best performing...
